DiscoverThe Bio ReportCell Therapies that Can Do a Solid for People with Cancer
Cell Therapies that Can Do a Solid for People with Cancer

Cell Therapies that Can Do a Solid for People with Cancer

Update: 2024-10-23
Share

Description

In August, the U.S. Food and Drug Administration approved Adaptimmune’s Tecelra, the first engineered cell therapy to treat a solid tumor. The T cell receptor gene therapy is approved to treat synovial sarcoma, a rare soft tissue cancer that most often affects young adults. We spoke to Adrian Rawcliffe, CEO of Adaptimmune, about the approval, how TCR therapies differ from CAR T therapies, and what other cancers might benefit from such an approach.  

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Cell Therapies that Can Do a Solid for People with Cancer

Cell Therapies that Can Do a Solid for People with Cancer

Levine Media Group